Wedbush analyst David Nierengarten raised the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst PT Change

Pre-Open Stock Movers 12/17: (XSPA) (MGNX) (RAD) (ROKU) Higher; (QTT) (PHAT) (ABM) Lower (more...)December 17, 2020 9:22 AM MacroGenics (MGNX) PT Raised to $14 at BarclaysDecember 17, 2020 4:38 AM Zai Lab Partner MacroGenics Announces FDA Approval of MARGENZA™ for Patients with Pretreated Metastatic HER2-Positive Breast CancerDecember 16, 2020 8:16 PM Zai Lab Partner MacroGenics Announces FDA Approval of MARGENZA™ for Patients with Pretreated Metastatic HER2-Positive Breast CancerDecember 16, 2020 8:15 PM After-Hours Movers 12/16: (MGNX) (SELB) (ROKU) Higher; (QTT) (ABM) (GSX) Lower (more...)December 16, 2020 5:39 PM Form 8-K MACROGENICS INC For: Dec 16December 16, 2020 5:28 PM Macrogenics (MGNX) Announces FDA Approval of MARGENZA for Patients with Pretreated Metastatic HER2-Positive Breast CancerDecember 16, 2020 4:33 PM